SEC Company Response from ASSEMBLY BIOSCIENCES, INC. (ASMB) (CIK 0001426800) (ASMB) — Jan 14, 2015
ASSEMBLY BIOSCIENCES, INC. (ASMB) (CIK 0001426800)
Date: Jan. 14, 2015 · CIK: 0001426800 · Accession: 0001144204-15-002135
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-200612
Letter
ASSEMBLY BIOSCIENCES, INC.
99 Hudson Street, 5th Floor
New York, New York 10013
January 14, 2015
Via EDGAR Delivery
Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Attention: Johnny Gharib
Re: Assembly Biosciences, Inc.
Registration Statement on Form S-3
Filed November 26, 2014
File No. 333-200612
Ladies and Gentlemen:
Assembly Biosciences, Inc., a Delaware corporation (the “Registrant”), hereby requests that the Securities and Exchange Commission take appropriate action to make the Registrant’s Registration Statement on Form S-3 (File No. 333-200612) effective as of 4:00 p.m. Eastern Time, Thursday, January15, 2015, or as soon thereafter as practicable. Please advise our corporate counsel, Alexander M. Donaldson at (919) 781-4000, of any questions.
With respect to the aforementioned registration statement, the Registrant hereby acknowledges that:
· should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
· the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
· the Registrant will not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Very truly yours,
ASSEMBLY BIOSCIENCES, INC.
Show Raw Text
CORRESP 1 filename1.htm ASSEMBLY BIOSCIENCES, INC. 99 Hudson Street, 5th Floor New York, New York 10013 January 14, 2015 Via EDGAR Delivery Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Attention: Johnny Gharib Re: Assembly Biosciences, Inc. Registration Statement on Form S-3 Filed November 26, 2014 File No. 333-200612 Ladies and Gentlemen: Assembly Biosciences, Inc., a Delaware corporation (the “Registrant”), hereby requests that the Securities and Exchange Commission take appropriate action to make the Registrant’s Registration Statement on Form S-3 (File No. 333-200612) effective as of 4:00 p.m. Eastern Time, Thursday, January15, 2015, or as soon thereafter as practicable. Please advise our corporate counsel, Alexander M. Donaldson at (919) 781-4000, of any questions. With respect to the aforementioned registration statement, the Registrant hereby acknowledges that: · should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; · the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and · the Registrant will not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Very truly yours, ASSEMBLY BIOSCIENCES, INC. By: /s/ Russell H. Ellison Name: Russell H. Ellison Title: Chief Executive Officer